140 related articles for article (PubMed ID: 24452204)
1. Perinucleolar relocalization and nucleolin as crucial events in the transcriptional activation of key genes in mantle cell lymphoma.
Allinne J; Pichugin A; Iarovaia O; Klibi M; Barat A; Zlotek-Zlotkiewicz E; Markozashvili D; Petrova N; Camara-Clayette V; Ioudinkova E; Wiels J; Razin SV; Ribrag V; Lipinski M; Vassetzky YS
Blood; 2014 Mar; 123(13):2044-53. PubMed ID: 24452204
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 transcriptional activation in MCL.
Beà S
Blood; 2014 Mar; 123(13):1979-80. PubMed ID: 24677400
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 (CCND1) messenger RNA expression as assessed by real-time PCR contributes to diagnosis and follow-up control in patients with mantle cell lymphoma.
Bacher U; Kern W; Haferlach C; Alpermann T; Haferlach T; Schnittger S
Exp Hematol; 2013 Dec; 41(12):1028-37. PubMed ID: 24060591
[TBL] [Abstract][Full Text] [Related]
4. Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma.
Liu H; Huang J; Wang J; Jiang S; Bailey AS; Goldman DC; Welcker M; Bedell V; Slovak ML; Clurman B; Thayer M; Fleming WH; Epner E
J Exp Med; 2008 Aug; 205(8):1843-58. PubMed ID: 18625744
[TBL] [Abstract][Full Text] [Related]
5. Primary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): Diffuse large B-cell lymphoma with CCND1 rearrangement or mantle cell lymphoma?
Parrott AM; Haggiagi AM; Murty VV; Bhagat G; Alobeid B
Hematol Oncol; 2020 Dec; 38(5):817-822. PubMed ID: 32639587
[TBL] [Abstract][Full Text] [Related]
6. CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma.
Mohanty A; Sandoval N; Das M; Pillai R; Chen L; Chen RW; Amin HM; Wang M; Marcucci G; Weisenburger DD; Rosen ST; Pham LV; Ngo VN
Oncotarget; 2016 Nov; 7(45):73558-73572. PubMed ID: 27713153
[TBL] [Abstract][Full Text] [Related]
7. Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.
Masamha CP; Albrecht TR; Wagner EJ
J Hematol Oncol; 2016 Mar; 9():30. PubMed ID: 27025456
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
Al-Kawaaz M; Mathew S; Liu Y; Gomez ML; Chaviano F; Knowles DM; Orazi A; Tam W
Am J Clin Pathol; 2015 Feb; 143(2):288-99. PubMed ID: 25596256
[TBL] [Abstract][Full Text] [Related]
9. Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation.
Menke JR; Vasmatzis G; Murphy S; Yang L; Menke DM; Tun HW; King RL; Smoley SA; Ketterling RP; Sukov WR
Hum Pathol; 2017 Jun; 64():207-212. PubMed ID: 28132860
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities.
Chinen Y; Tsukamoto T; Maegawa-Matsui S; Matsumura-Kimoto Y; Takimoto-Shimomura T; Tanba K; Mizuno Y; Fujibayashi Y; Kuwahara-Ota S; Shimura Y; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
Exp Hematol; 2020 Apr; 84():45-53.e1. PubMed ID: 32145384
[TBL] [Abstract][Full Text] [Related]
11. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma.
Mohanty A; Sandoval N; Phan A; Nguyen TV; Chen RW; Budde E; Mei M; Popplewell L; Pham LV; Kwak LW; Weisenburger DD; Rosen ST; Chan WC; Müschen M; Ngo VN
Blood; 2019 Jan; 133(4):306-318. PubMed ID: 30530749
[TBL] [Abstract][Full Text] [Related]
12. Distinct Patterns of Colocalization of the CCND1 and CMYC Genes With Their Potential Translocation Partner IGH at Successive Stages of B-Cell Differentiation.
Sklyar I; Iarovaia OV; Gavrilov AA; Pichugin A; Germini D; Tsfasman T; Caron G; Fest T; Lipinski M; Razin SV; Vassetzky YS
J Cell Biochem; 2016 Jul; 117(7):1506-10. PubMed ID: 26873538
[TBL] [Abstract][Full Text] [Related]
13. An Uncommon Case of Double-Hit Mantle Cell Lymphoma That Demonstrates a Transformation Process.
Zhou J; Hu L; Zuo M; Zhou Y; Li G; Zhang X
Am J Clin Pathol; 2020 Jan; 153(1):49-57. PubMed ID: 31433838
[TBL] [Abstract][Full Text] [Related]
14. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
15. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
[TBL] [Abstract][Full Text] [Related]
16. Detection of cryptic CCND1 rearrangements in mantle cell lymphoma by next generation sequencing.
Polonis K; Schultz MJ; Olteanu H; Smadbeck JB; Johnson SH; Vasmatzis G; Xu X; Greipp PT; Ketterling RP; Hoppman NL; Baughn LB; Peterson JF
Ann Diagn Pathol; 2020 Jun; 46():151533. PubMed ID: 32408254
[TBL] [Abstract][Full Text] [Related]
17. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma.
Krieger S; Gauduchon J; Roussel M; Troussard X; Sola B
BMC Cancer; 2006 Oct; 6():238. PubMed ID: 17022831
[TBL] [Abstract][Full Text] [Related]
18. The relative levels of cyclin D1a and D1b alternative transcripts in mantle cell lymphoma may depend more on sample origin than on CCND1 polymorphism.
Carrère N; Belaud-Rotureau MA; Dubus P; Parrens M; de Mascarel A; Merlio JP
Haematologica; 2005 Jun; 90(6):854-6. PubMed ID: 15951302
[TBL] [Abstract][Full Text] [Related]
19. Flipping the cyclin D1 switch in mantle cell lymphoma.
Hasanali Z; Sharma K; Epner E
Best Pract Res Clin Haematol; 2012 Jun; 25(2):143-52. PubMed ID: 22687450
[TBL] [Abstract][Full Text] [Related]
20. t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform.
Iaccarino I; Afify L; Aukema SM; Reddemann K; Schütt P; Flür M; Klapper W
Haematologica; 2018 Sep; 103(9):e432-e435. PubMed ID: 29773591
[No Abstract] [Full Text] [Related]
[Next] [New Search]
